Cellectar Biosciences, Inc.
CLRB
$3.17
-$0.09-2.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -43.34% | -63.36% | -57.32% | -65.26% | 143.48% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -12.41% | -34.75% | -22.58% | -26.15% | 8.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -42.11% | -62.06% | -54.78% | -64.00% | 131.99% |
|
|
|||||
| Total Current Assets | -42.11% | -62.06% | -54.78% | -64.00% | 131.99% |
| Net Property, Plant & Equipment | -23.78% | -28.45% | -27.71% | -25.86% | -25.03% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -41.20% | -60.78% | -53.39% | -62.61% | 110.95% |
|
|
|||||
| Total Accounts Payable | -64.91% | -51.66% | -27.61% | -47.60% | -55.27% |
| Total Accrued Expenses | 14.52% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.72% | 18.81% | 19.02% | 19.05% | 43.05% |
| Total Finance Division Other Current Liabilities | -76.06% | -93.28% | -87.30% | -90.24% | -81.21% |
| Total Other Current Liabilities | -76.06% | -93.28% | -87.30% | -90.24% | -81.21% |
| Total Current Liabilities | -49.41% | -75.82% | -61.32% | -78.91% | -62.98% |
|
|
|||||
| Total Current Liabilities | -49.41% | -75.82% | -61.32% | -78.91% | -62.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -24.46% | -22.23% | -20.29% | -18.57% | -17.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -48.36% | -74.70% | -60.13% | -77.93% | -62.10% |
|
|
|||||
| Common Stock & APIC | 6.14% | 10.05% | 12.82% | 16.39% | 42.75% |
| Retained Earnings | -8.81% | -7.69% | -12.62% | -10.70% | -21.99% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -41.80% | 382.54% | 22.63% | 269.33% | 169.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | -87.31% | -79.37% | -89.69% | -68.60% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | -87.31% | -79.37% | -89.69% | -68.60% |
|
|
|||||
| Total Common Equity | -41.80% | 382.54% | 22.63% | 269.33% | 169.44% |
| Total Preferred Equity | 0.00% | -87.31% | -79.37% | -89.69% | -68.60% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -36.73% | -43.32% | -45.75% | -30.60% | 213.79% |
|
|
|||||